Pharmacotherapy of cryptococcosis

Michele Ritter, David L. Goldman

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Cryptococcus neoformans is an opportunistic fungal pathogen that causes central nervous system and pulmonary disease among immunocompromised patients. Recent studies highlight the high incidence of cryptococcosis among patients in certain resource-poor areas, where there is also a high incidence of AIDS. Despite the availability of antifungal agents with anticryptococcal activity, the mortality and treatment-failure rates associated with cryptococcosis remain unacceptably high. This article reviews current treatment strategies and the basis for these strategies, as well as prospects for future approaches to the treatment of cryptococcosis.

Original languageEnglish (US)
Pages (from-to)2433-2443
Number of pages11
JournalExpert Opinion on Pharmacotherapy
Volume10
Issue number15
DOIs
StatePublished - Oct 2009

Fingerprint

Cryptococcosis
Drug Therapy
Cryptococcus neoformans
Antifungal Agents
Central Nervous System Diseases
Incidence
Immunocompromised Host
Treatment Failure
Lung Diseases
Acquired Immunodeficiency Syndrome
Mortality
Therapeutics

Keywords

  • Antifungal
  • Cryptococcosis
  • Meningitis
  • Pneumonia

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this

Pharmacotherapy of cryptococcosis. / Ritter, Michele; Goldman, David L.

In: Expert Opinion on Pharmacotherapy, Vol. 10, No. 15, 10.2009, p. 2433-2443.

Research output: Contribution to journalArticle

Ritter, Michele ; Goldman, David L. / Pharmacotherapy of cryptococcosis. In: Expert Opinion on Pharmacotherapy. 2009 ; Vol. 10, No. 15. pp. 2433-2443.
@article{bb45eb67ba7d4268b9aceb796f83cfa9,
title = "Pharmacotherapy of cryptococcosis",
abstract = "Cryptococcus neoformans is an opportunistic fungal pathogen that causes central nervous system and pulmonary disease among immunocompromised patients. Recent studies highlight the high incidence of cryptococcosis among patients in certain resource-poor areas, where there is also a high incidence of AIDS. Despite the availability of antifungal agents with anticryptococcal activity, the mortality and treatment-failure rates associated with cryptococcosis remain unacceptably high. This article reviews current treatment strategies and the basis for these strategies, as well as prospects for future approaches to the treatment of cryptococcosis.",
keywords = "Antifungal, Cryptococcosis, Meningitis, Pneumonia",
author = "Michele Ritter and Goldman, {David L.}",
year = "2009",
month = "10",
doi = "10.1517/14656560903200642",
language = "English (US)",
volume = "10",
pages = "2433--2443",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Informa Healthcare",
number = "15",

}

TY - JOUR

T1 - Pharmacotherapy of cryptococcosis

AU - Ritter, Michele

AU - Goldman, David L.

PY - 2009/10

Y1 - 2009/10

N2 - Cryptococcus neoformans is an opportunistic fungal pathogen that causes central nervous system and pulmonary disease among immunocompromised patients. Recent studies highlight the high incidence of cryptococcosis among patients in certain resource-poor areas, where there is also a high incidence of AIDS. Despite the availability of antifungal agents with anticryptococcal activity, the mortality and treatment-failure rates associated with cryptococcosis remain unacceptably high. This article reviews current treatment strategies and the basis for these strategies, as well as prospects for future approaches to the treatment of cryptococcosis.

AB - Cryptococcus neoformans is an opportunistic fungal pathogen that causes central nervous system and pulmonary disease among immunocompromised patients. Recent studies highlight the high incidence of cryptococcosis among patients in certain resource-poor areas, where there is also a high incidence of AIDS. Despite the availability of antifungal agents with anticryptococcal activity, the mortality and treatment-failure rates associated with cryptococcosis remain unacceptably high. This article reviews current treatment strategies and the basis for these strategies, as well as prospects for future approaches to the treatment of cryptococcosis.

KW - Antifungal

KW - Cryptococcosis

KW - Meningitis

KW - Pneumonia

UR - http://www.scopus.com/inward/record.url?scp=70349378486&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349378486&partnerID=8YFLogxK

U2 - 10.1517/14656560903200642

DO - 10.1517/14656560903200642

M3 - Article

VL - 10

SP - 2433

EP - 2443

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

IS - 15

ER -